drugset / Trial / NCT01603069
A Study to Assess Safety and Tolerability of Oral AZD3241 in Patients With Parkinson's Disease
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a study where AZD3241 or placebo is given to patients with Parkinson's disease in a blinded and randomized assignment. The main objective is to see if safety and tolerability of the drug is acceptable.
Timeline
- Start
- 2012-10
- Primary completion
- 2013-06
- Completion
- 2013-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Verdiperstat | Small molecule | 300 mg | Oral |
| Comparator | Verdiperstat | Small molecule | 600 mg | Oral |